Latest News about ADGI
Recent news which mentions ADGI
Mid-Morning Market Update: Markets Mostly Higher; ISM Manufacturing Index Rises In September
October 01, 2021
From Benzinga
Adagio's COVID-19 Candidate Shows Prolonged Half-Life, Neutralization At Six Months
September 29, 2021
From Benzinga
48 Biggest Movers From Yesterday
September 29, 2021
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
September 28, 2021
From Benzinga
36 Stocks Moving In Tuesday's Mid-Day Session
September 28, 2021
From Benzinga
53 Biggest Movers From Yesterday
September 16, 2021
From Benzinga
38 Stocks Moving In Wednesday's Mid-Day Session
September 15, 2021
From Benzinga
46 Biggest Movers From Yesterday
September 15, 2021
From Benzinga
Mid-Afternoon Market Update: Dow Tumbles 300 Points; Communications Systems Shares Climb
September 14, 2021
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
September 14, 2021
From Benzinga
The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout
September 14, 2021
From Benzinga
72 Biggest Movers From Yesterday
September 14, 2021
From Benzinga
60 Biggest Movers From Friday
September 13, 2021
From Benzinga
Adagio Therapeutics To Expand Late-Stage COVID-19 Antibody Trial
September 10, 2021
Tickers
ADGI
From Benzinga
The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test
September 10, 2021
From Benzinga
53 Biggest Movers From Friday
September 07, 2021
From Benzinga
3 Biotech Stocks That Soared to New Heights Last Week
September 05, 2021
From Motley Fool
The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself
September 03, 2021
From Benzinga
The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab
September 02, 2021
From Benzinga
The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering
September 01, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 31, 2021
August 31, 2021
From Benzinga
The Week Ahead In Biotech (Aug. 29- Sept. 4): Merck's Keytruda Regulatory Decision, Stray Earnings On Tap In a Light Week
August 29, 2021
From Benzinga
78 Biggest Movers From Friday
August 16, 2021
From Benzinga
53 Stocks Moving In Friday's Mid-Day Session
August 13, 2021
From Benzinga
The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
August 13, 2021
From Benzinga
From Benzinga
66 Biggest Movers From Yesterday
August 12, 2021
From Benzinga
The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts
August 10, 2021
From Benzinga
84 Biggest Movers From Friday
August 09, 2021
From Benzinga